CMS Interoperability and Patient Access final rule and Health Samurai FHIR pl...HealthDev
Pavel Smirnov, CEO of Health Samurai.
CMS Interoperability and Patient Access final rule for health plans
CMS has released Patient Access final rule for health plans. By July 1, 2021, health plans must allow their members to access their claims and encounter information over standards-based secure API (FHIR® 4.0.1). Pavel analyzed the rule in detail and share the checklist that any health plan can use. Then he explained the technology that Health Samurai has built to allow health plans comply with the rule.
Simona Carini, Programmer with UCSF. Simona talks about the new collaboration between Open mHealth and the FHIR community to make the connection between patient-generated data and the clinical workflow possible.
CMS Interoperability and Patient Access final rule and Health Samurai FHIR pl...HealthDev
Pavel Smirnov, CEO of Health Samurai.
CMS Interoperability and Patient Access final rule for health plans
CMS has released Patient Access final rule for health plans. By July 1, 2021, health plans must allow their members to access their claims and encounter information over standards-based secure API (FHIR® 4.0.1). Pavel analyzed the rule in detail and share the checklist that any health plan can use. Then he explained the technology that Health Samurai has built to allow health plans comply with the rule.
Simona Carini, Programmer with UCSF. Simona talks about the new collaboration between Open mHealth and the FHIR community to make the connection between patient-generated data and the clinical workflow possible.
SMART on FHIR apps by Aziz Boxwala, MD, PhD at ScaleLAHealthDev
Aziz Boxwala, MD, PhD is the President of Elimu Informatics, Inc. a company with expertise in clinical decision-support and healthcare interoperability. Dr. Boxwala has authored and contributed to HL7 standards including FHIR.
He will provide an overview of the SMART-on-FHIR specification for creating apps that integrate with electronic health record systems, describe how these apps can be used to meet different workflow needs and provide clinical decision support. He will demonstrate Sapphire, a tool for assembling SMART-on-FHIR apps rapidly using a drag-and-drop interface.
Patenting activity in Intravenous (IV) Fluids. We have shown patenting activity by top assignees, top inventors, by publication year, by application year, by priority year, by top IPC class, by top US class, by top ECLA class and geographical patenting activity.
IHE product selection and acceptance testingCor Loef
IHE, Integrating the Healthcare Enterprise, creates solutions for interoperability problems in healthcare by developing standards based interface specifications. Healthcare ICT products that have implemented the IHE specifications make the integration efforts for an eHealth solution much easier. Conformity assessment in the deployment process towards an operational application portfolio is supported by a proven test methodology and Open Source test tools.
STATE OF MOBILE HEALTH on FHIR by Gora Datta at ScaleLAHealthDev
Gora Datta, CEO of CAL2CAL Corporation, HL7 International Ambassador, co-Chair of HL7 Mobile Health group, Board member of IEEE Southern California Council & Chair of IEEE Orange County CyberSecurity SIG.
Gora Datta will introduce the story behind what, why & how FHIR has become alphabet of interoperability in the mobile connected digital world we live in and how emerging Mobile Health standards are helping the way to a safe and secure world.
This slide deck was used to provide an introductory tutorial on the HL7 Clinical Document Architecture (CDA) standard. It has shared copyright with Health Level Seven. CDA is an HL7 document exchange standard.
II-SDV 2016 Michael Iarrobino - Improving Text Mining Results with Access to ...Dr. Haxel Consult
Life science companies increasingly rely on text mining to gain important insights from vast amounts of published information. But researchers struggle to get access to full-text articles for text mining. When they do get the full text they must contend with multiple formats and inconsistent license terms – all of which inhibit text mining efforts. In this presentation, we will describe the value in mining full-text scientific literature and outline the issues researchers face in accessing and licensing this content for commercial purposes. We will provide a walkthrough of Copyright Clearance Center’s (CCC) RightFind™ XML for Mining solution and contrast this with other approaches to solving these time-consuming content and licensing challenges. CCC is the parent organization of RightsDirect.
SMART on FHIR apps by Aziz Boxwala, MD, PhD at ScaleLAHealthDev
Aziz Boxwala, MD, PhD is the President of Elimu Informatics, Inc. a company with expertise in clinical decision-support and healthcare interoperability. Dr. Boxwala has authored and contributed to HL7 standards including FHIR.
He will provide an overview of the SMART-on-FHIR specification for creating apps that integrate with electronic health record systems, describe how these apps can be used to meet different workflow needs and provide clinical decision support. He will demonstrate Sapphire, a tool for assembling SMART-on-FHIR apps rapidly using a drag-and-drop interface.
Patenting activity in Intravenous (IV) Fluids. We have shown patenting activity by top assignees, top inventors, by publication year, by application year, by priority year, by top IPC class, by top US class, by top ECLA class and geographical patenting activity.
IHE product selection and acceptance testingCor Loef
IHE, Integrating the Healthcare Enterprise, creates solutions for interoperability problems in healthcare by developing standards based interface specifications. Healthcare ICT products that have implemented the IHE specifications make the integration efforts for an eHealth solution much easier. Conformity assessment in the deployment process towards an operational application portfolio is supported by a proven test methodology and Open Source test tools.
STATE OF MOBILE HEALTH on FHIR by Gora Datta at ScaleLAHealthDev
Gora Datta, CEO of CAL2CAL Corporation, HL7 International Ambassador, co-Chair of HL7 Mobile Health group, Board member of IEEE Southern California Council & Chair of IEEE Orange County CyberSecurity SIG.
Gora Datta will introduce the story behind what, why & how FHIR has become alphabet of interoperability in the mobile connected digital world we live in and how emerging Mobile Health standards are helping the way to a safe and secure world.
This slide deck was used to provide an introductory tutorial on the HL7 Clinical Document Architecture (CDA) standard. It has shared copyright with Health Level Seven. CDA is an HL7 document exchange standard.
II-SDV 2016 Michael Iarrobino - Improving Text Mining Results with Access to ...Dr. Haxel Consult
Life science companies increasingly rely on text mining to gain important insights from vast amounts of published information. But researchers struggle to get access to full-text articles for text mining. When they do get the full text they must contend with multiple formats and inconsistent license terms – all of which inhibit text mining efforts. In this presentation, we will describe the value in mining full-text scientific literature and outline the issues researchers face in accessing and licensing this content for commercial purposes. We will provide a walkthrough of Copyright Clearance Center’s (CCC) RightFind™ XML for Mining solution and contrast this with other approaches to solving these time-consuming content and licensing challenges. CCC is the parent organization of RightsDirect.
HANDI Summit 18 - Introducing HANDI-HOPD - Dr Ian McNicollHANDI HEALTH
NHS England hosted the HANDI-HOPD Summit in London on the 18th September. This was attended by an invited audience of around 40 people to discuss plans to take the HANDI-HOPD platform forward to the NHS England Open Source Open Day on the 26th of November in Newcastle-Upon-Tyne where is will be launched as the Platform for NHS Code4Health.
Dr Ian McNicoll, gave an overview of how the platform worked and a description of the key open standards and how the could be used by developers to rapidly build interoperable health and care software. He also described how the platform provided a rigorous process fro the development, curation and publication of clinical content models and facilitated the easy engagement of clinicians in the process.
HANDI Summit 18 - Introducing HANDI-HOPD - Ewan DavisHANDI HEALTH
NHS England hosted the HANDI-HOPD Summit in London on the 18th September. This was attended by an invited audience of around 40 people to discuss plans to take the HANDI-HOPD platform forward to the NHS England Open Source Open Day on the 26th of November in Newcastle-Upon-Tyne where is will be launched as the Platform for NHS Code4Health.
HANDI-HOPD The HANDI Open Platform Demonstrator provides an experimental platform to demonstrate the power of emerging open standards and APIs to deliver the transformational power of the Internet to support digital health and care.
Ewan Davis introduced the HOPD, described where it fitted in the global development of open health platforms what had already been deployed and our plans for it’s development.
Today's Electronic Health Record (EHR) offerings inhibit the ability to develop the next generation of clinical applications for providers to provide the best possible care and patients to become more engaged. Such offerings are designed as monolithic silos of storage and end-user experience that use proprietary methods for accessing key functionality. While large health care providers typically have physical control over their data, they lack in having functional control. This barrier makes it virtually impossible for data to be easily accessed by other applications without very costly and time-consuming migration strategies. As a result, the pace of innovation is greatly stymied by closed systems that appear to be all-too-prevalent in the healthcare industry. This session presents a strategy of vendor-neutral, public, open Application Programming Interfaces (APIs) and advocates for their use in developing open platforms for healthcare applications.
Data Harmonization for a Molecularly Driven Health SystemWarren Kibbe
Seminar for Dr. Min Zhang's Purdue Bioinformatics Seminar Series. Touched on learning health systems, the Gen3 Data Commons, the NCI Genomic Data Commons, Data Harmonization, FAIR, and open science.
Introduction to the 2012 Indivo X Users' Conference, including a history of Indivo and Personal Health Records, a discussion of the reasons for Google Health's demise, and how Indivo's open architecture might provide a solution.
By Kenneth Mandl, MD MPH, Faculty, Boston Children's Hospital Informatics Program.
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Supporting HANDI apps developers Arctic dual-modelling Conf Tromso 2014
1. Supporting the health ‘apps’ revolution
Software apps to support health and care - Supporting the app paradigm –
Creating a community of interest - That's HANDI
www.handihealth.org
Dr Ian McNicoll
HANDIHealth
openEHR Foundation
freshEHR Clinical Informatics
2. INTRODUCTION
2
Ian McNicoll
Former Glasgow GP
Health informatics
Director openEHR Foundation
freshEHR Clinical Informatics
Ocean Informatics UK
HANDIHealth
Commercial software developer
‘GP Accounts’
3. HANDI Health CIC
• A not-for-profit Community Enterprise
Company
• There to support:
– Developers
– Health and care professionals
– Patients, service users and carers
4. Apps: Lightweight Digital Tools
Not just about mobile
Narrow scope,a “connected thing”
Makes heavy use of pre-existing components
and services
Built using a well defined development and
deployment framework
Order of magnitude(s) faster and cheaper to
develop and deploy
Allows niche solutions and “fail fast”
5. What does HANDI do?
• Lobby for an environment (technical, cultural
and commercial) in which apps can flourish
interoperate and be orchestrated
6. HANDI is agnostic
• About
– Platforms
– Business models
– Standards
– Tools, services and approaches
• Show the community the possibilities and let
individuals decide
7. ‘open’
• Open data
– Analytics, quality monitoring
• Open APIs / standards
• ITK, GP2GP
• SMARTPlatform, FHIR
• Open source
– openEyes, Wardware
– Leeds Care Record
– Spine2
– “Safer Wards” Fund
7
8. Time for ‘open Platforms’?
• USA
• SMARTPlatforms
• Healthcare Services Collaboration Platform
• Intermountain, Cerner, Harris Healthcare
• GP Systems of Choice (GPSOC) refresh
• Phase 1 GP systems open APIs
• Phase 2 GP systems Common APIs
• De-facto ‘open platform’
8
13. The ‘HANDI Vision’
13
Apps
EPR
EHR PHR
PHR EMR
Meds
Repository
Drug KB
Terminology
Server
Service
Directory
CDS Service Pathways KB
Services/Repositories
Infrastructural Services
PDS/Record Discovery EWS ESB/Spine
Security
Broker
14. ‘Closed’ eHealth Platform
Proprietary Clinical Content / API
Proprietary value-
add components
Proprietary Querying and Persistence
Terminology
Server
Pathways KBESB/SpineITK Integration component
15. An open standards platform?
Closed OSS ClosedOSS
Vendor DVendor B Vendor CVendor A
API and messaging content based on open
source clinical content definitions
OSS
components
Vendor
solutions
Terminology
Server Pathways KB
ESB/SpineITK Integration component
Commit
Retrieve
16. ‘openEHR’ open Standards platform
Closed
source
Open
source
Open
source
openEHR
CDR
Vendor DVendor B Vendor CVendor A
Open source Archetype-based clinical
content information / querying model
OSS Value-add
components
Vendor
solutions
Terminology
Services Pathways KBESB/SpineITK Integration component
Commit
Retrieve
Query
17. Interoperability is not a tech problem
• Interoperability is a clinical problem
– Diverse recording practice (sometimes arbitrary)
– Diverse recording requirements
– Complexity / contextual nature of health data
– Lack of clinical involvement in standards development
• Too technical, too philosophical
• Too time-consuming, too slow
17
18. Current clinical content
standards methodology
• Antithesis of ‘agile’ development
– Inaccessible to clinicians
– Slow to develop, difficult to implement
– CDA implementation mostly ‘dumb documents’
– SNOMED has key role but ? oversold as whole solution
• Uncontrolled
– Multiple definitions of technical messaging models
• Approx 20 definitions of ‘allergy’ across UK
– No clear change request / problem report mechanism
18
19. Formal standards development
• “Arguably standards just get in the
way”
– Ewan Davis, HANDI
• Technical (ISB / ISO)
– Still largely a paper and
committee- bound process
• No clear problem
report/change request
mechanism
• Slow review cycles
• Professional (RCP ?PRSB)
– Aspirational guidelines
– Divorced from implementation
19
20. openEHR
Repository
(vendor #1)
openEHR
Repository [10]
(open source)
openEyes
(Moorfields)
“Safer Wards” Orsini
openEHR
Repository
(vendor #2)
openEHR API openEHR API
Local
SQL DB
openEHR API
Wardware2
(Kings)
NHS API
ESB / ITK / Spine components [2]
NHS Reporting
API
NHS
Care API
LCR apps
(Leeds)
openENT
(UCLP)
Clinical content
openEHR API integration [7]
EHRPaaS [9]
NHS API-
openEHR
Adaptors [8]
Professional
Records
Standards
Board
Professional oversight
21. open, shared data models: Archetypes
• Clinically-led + collaboratively authored
– open-source ‘crowd-sourcing’ methodology
– Shared open repository ‘CC-BY-SA’ licence
• Agility in response to continually changing clinical
demand
– Clear ownership, change request mechanism
– Tight version control
21
22.
23. Leeds NHS Care Record: open
Platform
openEHR Foundation accredited
Open Standards CDR Service layer
N3
hosted
ESB/Spine ITK Integration component
Commit
Retrieve
Query
OpenEHR Clinical Content “Archetypes”:
• Medication, allergies (GP2GP/ RCP/NHSS)
• Problems, procedures (international)
• End of Life content (ISB)
• Vital Signs, NEWS (international)
SMARTPlatforms
Open
APIs:
Leeds Clinical Portal via
SMARTPlatform APIs
‘OceanEHR’ Clinical
data repository
25. 25
SMARTPlatforms
Pluggable Webapp
API
HL7
Clinical Content
Exchange NHS API
inVivo
Datastore API
Detailed
Clinical Content
Development
Clinical leadership PRSB
Terminology
Centre
HSCIC
Non
openEHR
systems
Archetype+ SNOMED Clinical
Content definitions
A new mobile app
developer requires
plug in for care
record to test pulse
app functionality.
ITK+N3
29. NICE guidance on medicines reconciliation
Medication data models (RCP / GP2GP based)
Dummy Patient Health Record with realistic data
Data accessible via RESTful API
30. What did we set out to do?
• Create a patient-facing web-page for medication
reconciliation
• Populate existing medication list from GP system or
other source
• Enable patient to mark each item as
– Taking as prescribed / Changed dose
– No longer taking / Add new medication
• Save reconciled record back to server for onwards
transmission to GP
30
38. next tech steps for HANDI-HOPD
SMART and HL7 FHIR support
More openEHR providers
Cross provider querying demos
Cross provider transfers
Focus for openEHR ‘in-vivo’ API alignment
discussions
38
39. next steps for HANDI-HOPD?
• Direct discussion with NHS England
• possible use by Code4Health
• possible direct support for the ‘open
standards platform’ approach
• HOPD-HACKD hackday event in
September
39
40. Links
• twitter: @ianmcnicoll
• HANDI-HOPD handi-hopd.org/demo
• Ehrscape: dev.ehrscape.com
• Leeds Innovation Lab Health Platform : http://leedslabplatform.com
• openEHR Foundation : www.openehr.org
• International archetype repository: www.openehr.org/ckm
• UK archetype repository: www.clinicalmodels.org.uk